FSMAX
Price
$96.46
Change
-$0.29 (-0.30%)
Updated
Aug 15 closing price
Net Assets
39.63B
IPMSX
Price
$19.48
Change
-$0.09 (-0.46%)
Updated
Aug 15 closing price
Net Assets
765.63M
Interact to see
Advertisement

FSMAX vs IPMSX

Header iconFSMAX vs IPMSX Comparison
Open Charts FSMAX vs IPMSXBanner chart's image
Fidelity Extended Market Index
Price$96.46
Change-$0.29 (-0.30%)
VolumeN/A
Net Assets39.63B
Voya Index Plus MidCap Port S
Price$19.48
Change-$0.09 (-0.46%)
VolumeN/A
Net Assets765.63M
FSMAX vs IPMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. IPMSX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and IPMSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.6B vs. IPMSX (766M). FSMAX pays higher dividends than IPMSX: FSMAX (0.46) vs IPMSX (0.41). FSMAX was incepted earlier than IPMSX: FSMAX (14 years) vs IPMSX (24 years). IPMSX (0.91) is less costly to investors than FSMAX (0.04). IPMSX is a more actively managed with annual turnover of: 60.00 vs. FSMAX (9.00). FSMAX (0) and IPMSX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 16.65 vs. IPMSX (-1.13). FSMAX return over 5 years is better than : 52.87 vs. IPMSX (17.15).
FSMAXIPMSXFSMAX / IPMSX
Total Expense Ratio0.040.854%
Annual Report Gross Expense Ratio0.040.914%
Fund Existence14 years24 years-
Gain YTD6.140-5.839-105%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets39.6B766M5,170%
Annual Yield % from dividends0.460.41111%
Returns for 1 year16.65-1.13-1,476%
Returns for 3 years34.548.22420%
Returns for 5 years52.8717.15308%
Returns for 10 years84.94-3.80-2,233%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KROS14.480.06
+0.42%
Keros Therapeutics
CHAR10.34N/A
N/A
Charlton Aria Acquisition Corporation
GFS33.07-0.03
-0.09%
GlobalFoundries
CLSK9.75-0.20
-2.01%
CleanSpark
KZIA8.03-0.23
-2.84%
Kazia Therapeutics Limited